-
Study aim
-
Determination of hemostatic effect of transamine in percutaneous nephrolithotomy.
-
Design
-
Clinical trials have two groups: patient and control, which is a blind side.At the beginning of the study, patients receive their own number regardless of the information in the file, which will be randomly assigned to the patient and control group.
-
Settings and conduct
-
This study was performed in patients who referred to Baqiyatallah Hospital who underwent surgery to remove a kidney stone.Patients in the patient group will receive the ampoule of transaminase according to a specific schedule, and participants in the control group will receive distilled water by inducing the same drug.
-
Participants/Inclusion and exclusion criteria
-
Participants in this study must be between 18 and 60 years old and weigh between 60 and 99 kg, and have no history of anticoagulant use or blood diseases.Therefore, patients under 18 years of age or over 60 years of age and weighing less than 60 kg and over 99 kg, as well as people with a history of anticoagulant use and a history of blood diseases will be excluded from the study.
-
Intervention groups
-
In this study, in order to investigate the coagulation effect of transaminase, a 500 mg trans amine ampoule will be used during surgery and also every 8 hours after surgery for 48 hours in the patient group And for the control group, distilled water vial will be used with the same program.
-
Main outcome variables
-
Decreased hemoglobin, blood transfusion, change in vital signs, heart attack, stroke, pulmonary thromboembolism, deep vein thrombosis